End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | +5.56% | +11.76% | -5.00% |
04-30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
04-10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
15.03M | - | |||||
728B | ||||||
603B | ||||||
360B | ||||||
332B | ||||||
279B |
- Stock Market
- Equities
- SNT Stock
- Charts Syntara Limited
- Sector Chart